Azusa Nagao, MD, MSc, PhD

Stuff physician
Department of Blood Coagulation, Ogikubo Hospital
Tokyo, Tokyo, Japan

Azusa Nagao, M.D., M.Sc., Ph.D., is an Internal Medicine Specialist and Board-certified expert in Thrombosis and Hemostasis at Ogikubo Hospital in Tokyo, one of Japan's largest hemophilia treatment centers. Dr. Nagao is also appointed as a researcher at the Department of Hematology-Oncology at Kansai Medical University Hospital. She is recognized nationally as an authority in musculoskeletal ultrasonography for hemophilia patients. Her research interests include addressing issues related to women with bleeding disorders, aging in hemophilia, and comprehensive hemophilia care. Dr. Nagao has published extensively in leading journals and collaborates internationally on clinical trials and registries advancing hemophilia treatment.

Presentation(s):

• OC 14.6 - Surgery in hemophilia and rare bleeding disorders

  Sunday, June 23, 2024
  09:30 – 10:45 ICT

• OC 27.4 - Wide Individual variation of emicizumab concentrations and surrogate factor VIII activity assessed by human factor-based chromogenic substrate assay in hemophilia A patients without inhibitor

  Sunday, June 23, 2024
  15:30 – 15:45 ICT

• PB0572 - Specific bleeding symptoms for detection of bleeding disorders

  Monday, June 24, 2024
  13:45 – 14:45 ICT

• PB0495 - Treatment of Thrombotic Cardiovascular Diseases in People with Haemophilia: A Japanese Consensus Study

  Monday, June 24, 2024
  13:45 – 14:45 ICT

• OC 50.4 - Assessment of global coagulation function under treatment with emicizumab concomitantly with bypassing agents in hemophilia A with inhibitor (UNEBI Study): Multicenter open-label non-randomized trial.

  Tuesday, June 25, 2024
  10:15 – 10:30 ICT